Search

Philipp H Schmaelzle

from Mountain View, CA
Age ~44
Get Report
Also known as:
Schmaelzle Philipp, Philipp E
Connected to:
Barbara J Schmaeling, 61Pamela A Schmagel, 58Amparo H Schmahmann, 69Carl R Schmahl, 75Donna L Schmahl, 57Randall L Schmahl, 73Tim Schmahl, 81Linda M Schmaing, 63Patrick J Schmaing, 75Carol L Schmal, 66

Philipp Schmaelzle Phones & Addresses

  • Mountain View, CA
  • Los Altos, CA

Work

Company: Google Nov 2012 Position: Entrepreneurial scientist

Education

Degree: Dipl. Ing. EE School / High School: University of Karlsruhe (KIT) 2000 to 2006 Specialities: Light Technology Institute

Skills

Technology • Technology Development • Development

Industries

Research

Resumes

Resumes

Philipp Schmaelzle Photo 1

Hardware Engineer And Entrepreneurial Scientist

View page
Location:
Mountain View, CA
Industry:
Research
Work:
Google since Nov 2012
Entrepreneurial Scientist
Palo Alto Research Center (PARC) 2007 - Oct 2012
Member of Research Staff
Fraunhofer IOF (Institute of Applied Optics), Jena 2006 - 2007
Research Scientist
Education:
University of Karlsruhe (KIT) 2000 - 2006
Dipl. Ing. EE, Light Technology Institute University of Sydney 2003 - 2003
Skills:
Technology
Technology Development
Development

Publications

Us Patents

Self-Adjusting Solar Light Transmission Apparatus

View page
US Patent:
8040609, Oct 18, 2011
Filed:
Nov 29, 2010
Appl. No.:
12/955743
Inventors:
Philipp H. Schmaelzle - Los Altos CA, US
Gregory L. Whiting - Mountain View CA, US
Joerg Martini - San Francisco CA, US
David K. Fork - Mountain View CA, US
Patrick Y. Maeda - Mountain View CA, US
Assignee:
Palo Alto Research Center Incorporated - Palo Alto CA
International Classification:
F24J 2/00
F24J 2/46
H02N 6/00
US Classification:
359591, 136246, 136 89, 356415, 356432, 356445, 356446, 126589, 126585
Abstract:
A self-adjusting solar light transmission (daylighting) apparatus includes a sunlight concentrating member (e. g. , a lens array) for concentrating direct sunlight in focal zone regions disposed inside a sheet containing an evenly-distributed stimuli-responsive material (SRM) that has a relatively high transparency state in the absence of concentrated sunlight, and changes to a relatively opaque (light scattering or absorbing) state in small portions located in the focal zone regions in response to concentrated direct sunlight. Thereby, 80% or more of direct sunlight is prevented from passing through the apparatus, but 80% or more of diffuse light is passed. The outer sheet surfaces are locally parallel (e. g. , planar) such that sunlight scattered by the light-scattering SRM portions is transmitted by total internal reflection through the remaining transparent sheet material, and outcoupled to one or more optional solar energy absorbing structures (e. g. , heatsinks or PV cells) disposed along the peripheral edge of the sheet.

Multiple-Source Multiple-Beam Polarized Laser Scanning System

View page
US Patent:
8139277, Mar 20, 2012
Filed:
Jan 20, 2010
Appl. No.:
12/690754
Inventors:
Patrick Yasuo Maeda - Mountain View CA, US
Philipp Helmut Schmaelzle - Los Altos CA, US
Assignee:
Palo Alto Research Center. Incorporated - Palo Alto CA
International Classification:
G02B 26/08
US Classification:
3592041
Abstract:
Two integrated multi-beam sources are positioned and disposed such that each emits light toward an optical splitter. The emitted light is polarized such that the splitter brings the optical paths of the two integrated multi-beam sources generally parallel to one another such that the optical system aperture throughput for the two integrated multi-beam sources is roughly the same as for a single integrated multi-beam source. The splitter may be such that a portion of the optical energy from each source is directed into an imaging path and a portion of the optical energy is directed toward one or more non-polarizing splitters and optical sensors for, inter alia, controlling the output of the sources. In various embodiments, the number of splitters, and hence the extent of optical loss, may be reduced by use of a combined polarized and non-polarized splitter, dual polarized splitters, and time-sequenced beam generation and monitoring.

Stationary Sunlight Redirecting Element And System

View page
US Patent:
8223433, Jul 17, 2012
Filed:
Aug 9, 2010
Appl. No.:
12/853258
Inventors:
Philipp H. Schmaelzle - Los Altos CA, US
Matthew D. Eisaman - Redwood City CA, US
Patrick Y. Maeda - Mountain View CA, US
Assignee:
Palo Alto Research Center Incorporated - Palo Alto CA
International Classification:
G02B 17/00
G02B 27/00
US Classification:
359593, 359597
Abstract:
A low-cost sunlight redirecting element including multiple substantially identical redirecting structures uniformly arranged and fixedly disposed on a base, where each redirecting structure includes multiple optical surface regions that are cooperatively formed and arranged such that, when the sunlight redirecting element is operably fixedly oriented relative to a stationary target with sunlight directed along an incident direction onto the redirecting structures, at least some of the sunlight is transmitted between the corresponding optical surface regions of each redirecting structure, and redirected from the corresponding optical surface regions toward the target's surface. The optical surface regions are shaped and arranged to redirect the sunlight toward the fixed target surface even when the sunlight's incident angle direction changes during the course of a year. A stationary sunlight redirecting system (e. g. , an architectural daylighting arrangement or PV farm) includes the sunlight redirecting element maintained in a fixed relationship to the stationary target surface.

Drug Deactivation System

View page
US Patent:
8236238, Aug 7, 2012
Filed:
Jan 21, 2009
Appl. No.:
12/357224
Inventors:
Scott Albert Uhland - Redwood City CA, US
Eric Peeters - Mountain View CA, US
Francisco E. Torres - San Jose CA, US
Philipp Helmut Schmaelzle - Los Altos CA, US
Assignee:
Palo Alto Research Center Incorporated - Palo Alto CA
International Classification:
A61L 2/00
US Classification:
422 22, 588900
Abstract:
A drug deactivation system according to some embodiments includes at least one drug-retaining region of a drug delivery device and at least one energy source coupled to the at least one drug-retaining region. The at least one drug-retaining region may be configured to retain a drug. The at least one energy source may be configured to transmit energy to the drug. The drug is capable of being rendered ineffective in the presence of the transmitted energy.

Drug-Transfer Device, Drug-Delivery System Incorporating The Same, Methods Of Fabricating The Same, And Methods Of Enabling Administration Of A Drug

View page
US Patent:
8257736, Sep 4, 2012
Filed:
Jun 30, 2009
Appl. No.:
12/495494
Inventors:
Philipp Helmut Schmaelzle - Los Altos CA, US
Scott Albert Uhland - Redwood City CA, US
Assignee:
Palo Alto Research Center Incorporated - Palo Alto CA
International Classification:
B65D 1/09
US Classification:
424454, 206528, 206532
Abstract:
A method of fabricating a drug-transfer device includes forming a package having a first component retaining multiple volumes of a drug and a second component retaining an agent. The first component and the second component are integrally formed together. The agent is configured to suppress a physiological effect of the drug when the agent contacts the drug or is coadministered with the drug. The method allows exterior surfaces of the first and second components to be cleanable (e. g. , prior to final assembly). After such cleaning, either no or substantially no amount of drug and agent is present outside the package. According to some embodiments, the package may be fabricated such that either no or substantially no amount of the drug is present within the second component and such that either no or substantially no amount of the agent is present within the first component.

Drug-Transfer Device, Drug-Delivery System Incorporating The Same, Methods Of Fabricating The Same, And Methods Of Enabling Administration Of A Drug

View page
US Patent:
8313456, Nov 20, 2012
Filed:
Jun 30, 2009
Appl. No.:
12/495470
Inventors:
Philipp Helmut Schmaelzle - Los Altos CA, US
Scott Albert Uhland - Redwood City CA, US
Assignee:
Palo Alto Research Center Incorporated - Palo Alto CA
International Classification:
A61M 31/00
US Classification:
60410301, 6048901, 222592, 2225417, 222553, 234 1
Abstract:
Devices capable of deterring or preventing bulk extraction of drugs from, for example, drug-delivery systems are exemplarily disclosed. In one embodiment, such a device may include a package releasably retaining a drug and an agent. The agent is configured to suppress a physiological effect of the drug when the agent contacts the drug or is coadministered with the drug. The cell package is configured such that an amount of the drug is selectively releasable with respect to the agent when the package is operably proximate to an encoded key. The package, however, may be configured to impose a relatively high likelihood that either the drug will not be accessed or the drug will be contaminated by the agent if access to the contents of the package is sought without the use of an encoded key.

Drug-Transfer Device, Drug-Delivery System Incorporating The Same, Methods Of Fabricating The Same, And Methods Of Enabling Administration Of A Drug

View page
US Patent:
8317749, Nov 27, 2012
Filed:
Jun 30, 2009
Appl. No.:
12/495485
Inventors:
Philipp Helmut Schmaelzle - Los Altos CA, US
Scott Albert Uhland - Redwood City CA, US
Assignee:
Palo Alto Research Center Incorporated - Palo Alto CA
International Classification:
A61M 37/00
A61M 31/00
G06F 17/00
B65D 47/10
G06K 1/00
US Classification:
6041031, 604 82, 700 90, 2225417, 234 1
Abstract:
A method of enabling administration of a drug includes determining, within a drug-transfer device including cells, a location of at least one cell and generating information identifying the determined location. A user may be provided with the drug-transfer device. The drug is retained within the at least one cell when the user is provided with the drug-transfer device. The method also includes encoding a key with the information and providing the user with the key before, after or when the user is provided with the drug-transfer device. Drug retained within the at least one cell is selectively releasable when the key is operably proximate to the drug-transfer device and is encoded with the information. The key can be encoded with the information before and/or after being provided to the user. In some embodiments, the key is encoded based on instructions transmitted over a network.

Luminescent Solar Concentrator With Distributed Outcoupling Structures And Microoptical Elements

View page
US Patent:
8354628, Jan 15, 2013
Filed:
Aug 9, 2010
Appl. No.:
12/853266
Inventors:
Philipp H. Schmaelzle - Los Altos CA, US
Robert A. Street - Palo Alto CA, US
Assignee:
Palo Alto Research Center Incorporated - Palo Alto CA
International Classification:
G01C 21/82
F21V 9/16
H02N 6/00
F24J 2/10
US Classification:
2502034, 2504581, 136247, 126684
Abstract:
A luminescent solar concentrator including a light-guiding slab containing a luminescent material that generates light emissions in response to received sunlight, spaced-apart outcoupling structures that provide a distributed outcoupling of the light emissions through predetermined locations on one of the “broadside” (e. g. , upper or lower) surfaces of the light-guiding slab, and optical elements positioned to redirect the outcoupled light emissions such that the light emissions are concentrated onto a predetermined target (e. g. , a PV cell). Each optical element includes a collimating surface portion and optional returner surface.
Control profile
Philipp H Schmaelzle from Mountain View, CA, age ~44 Get Report